$MDHI = $1pps on Fundamentals alone per CEO, you won't find

New Post Public Reply Private Reply Replies (0) Message Board
blue_steelA60
$MDHI = $1pps on Fundamentals alone per CEO, you won't find a more solid OTC company, that's a FACT! 

http://youtu.be/-TUSPR9QXw4 



Fully Reporting 
100% SEC Compliant 
Profitable 
Debt Free 
6M Low Float 
Medicare & Medicaid
VA Deal Closing soon 
International & Global Presence (deals in the works)
Rapidly Increasing High Margin Revenue on Monthly Monitoring Fee'$ 
Acquisition of Medical Sales Group 51% (assets of $1M cash, $300k LOC) 
Revenue UP 533% YOY  HIGH MARGIN REVENUE$ (Monthly Serice Fee$)
2 Minute Commercials Aired Entire Month of November 
APS Deal with 1.4 Million Members 
3 New Employees 
Costco 4.5 star rating 
New Technology 

MediPendant & iHelp, the future of senior and elderly care!

MDHI continues it's growth trajectory, the PERS market is a $14B industry and expected to reach $20B within the next 5 year, MDHI will be a MAJOR Player.  

This is an OTC Investment, BUY n HOLD = Real Company, Real Product, Real Revenue$$$$$$$$$ 

and let's not forget CEO Ronnie Adams, recipient of prestigious Entrepreneurial of the Year Award 1996, Sponsored by Dow Jones, NASDAQ, Ernst & Young quoted REVENUE$ will be 2-3 x HIGHER this year!

MDHI $1pps was a conservative estimate based on fundamental, MDHI is a STRONG BUY

do your own DD, this is an opportunity that's window is closing. GL 
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Evaluating Planet Labs' Stock Surge: Is It Still Worth Buying?

Updated Category News Views 92

Planet Labs Stock Soars: A Close Look The stock has experienced remarkable growth this year, surging by 340% year-to-date. An impressive 37% increase occurred in just one day, showcasing investor enthusiasm following a strong earnings report. Planet Labs was trading at around $3.97 per share at the start of 2025. Fast forward almost a year, and the stock has climbed to...

Continue Reading
Capricor Therapeutics: Important Class Action Details to Know

Updated Category News Views 188

Understanding the Class Action Lawsuit Against Capricor Therapeutics It is crucial for investors of Capricor Therapeutics, Inc. to stay updated regarding the ongoing class action lawsuit. If you have invested in the company's securities within the established timeframe, you may have a valid claim to pursue compensation. Key Dates and Deadlines Investors who purchased...

Continue Reading
Unforgettable Wines from Friuli Venezia Giulia Showcase

Updated Category News Views 136

Experience the Wines of Friuli Venezia Giulia in New York An incredible showcase awaits wine lovers as the Wines of Friuli Venezia Giulia make a spectacular debut on the vibrant streets of New York City. This immersive tasting experience brings together the renowned wine producers from one of Italy's most influential wine regions, allowing guests to appreciate the unique...

Continue Reading
Why Energy Fuels ($UUUU) Is a Stellar Long-Term Bet

Updated Category News Views 166

Let’s Talk Energy Fuels and Its Decade-Long Ride Alright, folks, grab a cup of coffee and buckle up because we’re diving into Energy Fuels (AMEX:UUUU) like a hawk diving on a field mouse. This is the kind of stock that if you’d thrown down a grand ten years ago, it’d be worth a jaw-dropping $8,394.74 now—yeah, you heard me right! It’s been producing an average...

Continue Reading
Purpose Investments Inc. Reveals Monthly Distributions for ETFs

Updated Category News Views 72

Monthly Distribution Announcement by Purpose Investments PURPOSE INVESTMENTS INC. is excited to share the distributions scheduled for October across its open-end exchange traded funds and closed-end funds. The upcoming disbursements aim to provide transparency to investors and stakeholders, informing them about the financial performance and expected returns of the Funds....

Continue Reading